National Comprehensive Cancer Network

Subscriptions & Products
For Patients

About NCCN

Multiple Myeloma Panel - Disclosures as of 9/2/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Melissa Alsina, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Ortho Biotech Products, L.P.

None

None

12/3/2009

Kenneth C. Anderson, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

12/22/2009

William Bensinger, MD

Celgene Corporation;
Genzyme Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.;
Geron

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

11/30/2009

J. Sybil Biermann, MD

None

None

None

None

10/29/2009

Asher Chanan-Khan, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

11/3/2009

Adam D. Cohen, MD

None

Amgen Inc.;
Celgene Corporation

None

None

7/1/2009

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation;
Takeda Pharmaceuticals North America, Inc.

None

None

9/29/2009

Benjamin Djulbegovic, MD, PhD

Millennium Pharmaceuticals, Inc.

None

None

None

9/29/2009

Edward A. Faber, Jr., DO, MS

None

None

None

None

12/28/2009

Lauren Gallagher, RPh, PhD

None

None

None

None

8/23/2010

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

8/30/2010

Carol Ann Huff, MD

Bristol-Myers Squibb Company;
Geron

None

None

None

4/14/2010

Adetola Kassim, MD, MS

None

None

None

None

12/11/2009

Rashmi Kumar, PhD

None

None

None

None

7/15/2010

Gwynn Long, MD

       

Pending

Joan S. McClure, MS

None

None

None

None

7/18/2010

Bruno C. Medeiros, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
NOCR

None

None

1/25/2010

Ruby Meredith, MD, PhD

None

None

None

None

1/26/2010

Noopur Raje, MD

AstraZeneca Pharmaceuticals LP

Amgen Inc.;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

12/21/2009

Jeffrey Schriber, MD

None

Celgene Corporation;
Enzon Pharmaceuticals;
Genzyme Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Celgene Corporation

None

12/22/2009

Dorothy Shead, MS

None

None

None

None

7/18/2010

Seema Singhal, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

12/22/2009

George Somlo, MD

American BioSciences Inc.;
AstraZeneca Pharmaceuticals LP;
National Cancer Institute;
Abraxane

Bristol-Myers Squibb Company;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.

None

None

11/2/2009

Keith Stockerl-Goldstein, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

12/16/2009

Steven P. Treon, MD, PhD

       

Pending

Guido Tricot, MD, PhD

None

None

None

None

9/29/2009

Donna M Weber, MD

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Ortho Biotech Products, L.P.

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
proteolix

None

None

4/14/2010

Joachim Yahalom, MD

None

None

None

None

11/20/2009

Furhan Yunus, MD, FACP

None

None

None

None

7/10/2009

 

NCCN Website Supporters